Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10272184
Hydrogel membrane for adhesion prevention
granted -
US 10272158
Compounds for treating biofilm infection
granted -
US 10272137
Compositions and methods relating to myomaker-induced muscle cell fusion
granted -
US 10272084
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
granted -
US 10272099
Tumor-selective combination therapy
granted -
US 10272069
Methods of treating muscular dystrophy
granted -
US 10265439
Injectable cell-laden biohybrid hydrogels for cardiac regeneration and related applications
granted -
US 10265405
Polymers for delivery of factor VIII and/or factor IX
granted -
US 10265338
Compounds and methods for treating neurological and cardiovascular conditions
granted -
US 10267786
Systems and methods for high-resolution imaging
granted -
US 10258631
Formulations of testosterone and methods of treatment therewith
granted -
US 10258613
Compositions for treating retinal degeneration and methods of production and use thereof
granted -
US 10253424
Porous particles and methods of making thereof
granted -
US 10251909
Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
granted -
US 10251398
Improving shelf life and color profile of resin compositions with silver nanoparticles
granted -
US 10238770
Reparative cell isolation and delivery
granted -
US 10238655
Dihydroindene and tetrahydronaphthalene compounds
granted -
US 10238626
Therapeutic compounds
granted -
US 10240130
CDNA clone-launched platform for high-yield production of inactivated zika virus
granted -
US 10238698
Biomarkers and combination therapies using oncolytic virus and immunomodulation
granted -
US 10233438
Engineered primate L-methioninase for therapeutic purposes
granted -
US 10231947
Isochroman compounds and methods of use thereof
granted -
US 10231955
Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
granted -
US 10231958
Methods and compositions for enhancing chemotherapy
granted